NCT05569252 - A Study of DS-1211b in Individuals With PseudoXanthoma Elasticum | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 20, 2022

Primary Completion Date

November 21, 2023

Study Completion Date

November 21, 2023

Conditions

Pseudoxanthoma Elasticum

Interventions

DRUG

DS-1211b

DS-1211b tablet administered once daily in the morning either in the fasted state or with a meal

OTHER

Placebo

Placebo tablet administered once daily in the morning either in the fasted state or with a meal

Trial Locations (7)

UMC Utrecht, Utrecht

Clinilabs, New York

Clinical Research of Philadelphia, LLC, Philadelphia

Mid-Atlantic Epilepsy and Sleep Center, Bethesda

Boston Neuro Research Center, North Dartmouth

Infinity Medical Research Inc, North Dartmouth

Frontage Clinical Services, Inc., Secaucus